Acetilcisteína: Una actualización clínica y farmacológica sobre su efecto mucolítico. Estudio de revisión / Acetylcisteine. A clinical and pharmacological actualization with special. Reference to its mucolytic efect
Prensa méd. argent
; 105(10): 667-677, oct 2019. fig, graf
Artigo
em Espanhol
| BINACIS, LILACS
| ID: biblio-1025940
Biblioteca responsável:
AR392.1
ABSTRACT
The authors present a clinical and farmacological evaluation of the effect and safety of N-acetylcysteine in chronic obstructive diseases. The N-actylcysteine (NAC) is a sulphorated amino acid employed as an mucolytic agent. The efficacy and tolerability of oral NAC as compared with other agents was determined, in the mucolytic treatment on mucus hypersecretion and in the management of respiratory tract fluids and sputums from cigarette smokers, and also as a bronchial mucus fluidifying agent. A sistematic review and analysis of the effect of NAC and its effectiveness. In the treatment of acute respiratory disorders in children was determined
Base de dados:
BINACIS
/
LILACS
Assunto:
Acetilcisteína
/
Bromoexina
/
Mucosa Respiratória
/
Muco
Limite:
Humanos
Idioma:
Espanhol
Revista:
Prensa méd. argent
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS